Search our Innovation Portfolio

My NeuroResponse Pathway: Self-assessment and triage at your fingertips: A bespoke Digital service for people living with long-term neurological conditions to avoid ED attendance.

We aim to create a solution that links to NHS systems and is available to clinicians and patients via the NHS library. We are committed to creating a multifactorial integrated systems solution. 

We aim to create a solution that links to NHS systems and is available to clinicians and patients via the NHS library. We are committed to creating a multifactorial integrated systems solution encompassing:  

1. Self-assessment of non-urgent symptoms 24/7 by bespoke App 
2. Patient empowered access to order agreed tests 
3. Accessible personalized triage care with NHS 111 and other care partners 
4. Communication links between generalist and specialists primary & secondary care teams 
5. Triage directly via NHS 111 to primary care services to minimize presentation to ED 

Technology highlight: The NeutroCheck device will rapidly identify chemotherapy patients at risk of a life-threatening complication called neutropenic sepsis. Through better triaging, Neutrocheck has the potential to save hundreds of UK lives per year, free-up healthcare resources, and make patients' lives easier, simpler, and better.  

Technology summary: Even a mild illness can put chemotherapy patients at risk of developing a condition called neutropenic sepsis. Neutropenic sepsis is a life-threatening emergency, so patients are rushed to hospital if they show any symptoms. However, 50% of patients turn out not to have the condition, and therefore suffer unnecessary stress and receive unnecessary antibiotics. NeutroCheck is a fast, reliable and low-cost device to test for suspected neutropenic sepsis at home. NeutroCheck enables rapid management of the condition for those who test positive, and gives peace of mind to those who don't. Neutrocheck aims to improve patient safety and quality of life, reducing antibiotic wastage, and empowering doctors to treat their patients efficiently. 

Neutrocheck helps rapidly identify chemotherapy patients at risk of neutropenic sepsis. Through better triaging, Neutrocheck has the potential to save lives, reduce the burden on emergency care, improve quality of life and reduce carbon emissions. This project aims to further improve Neutrocheck’s net zero impact and develop industry-first carbon-related electronic measures of patient reported outcomes (PROMs).